However, at least some of the recent surge in first doses could also be from incorrectly reported booster shots
Third BNT162b2 Vaccine Dose May Cut Severe COVID-19 Outcomes
Fewer hospital admissions, cases of severe disease, COVID-19-related deaths seen with third dose versus two doses received five months ago
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 1 to 5, 2021. This …
Allergy History May Up Risk for Reactions to mRNA COVID-19 Vaccine
Risk for allergic reactions within three days of vaccination higher for those with history of high-risk allergy, but most completed the two-dose regimen
mRNA COVID-19 Efficacy Lower for Immunocompromised Adults
Vaccine effectiveness of two doses of mRNA vaccine lower against COVID-19-associated hospitalization, with variation by condition
White House Sets Jan. 4 Deadline for Large, Private U.S. Companies to Mandate Vaccines
Companies must give workers paid time off to get vaccinated and sick leave if they have any side effects
CDC Panel Signs Off on Pfizer Vaccine for Younger Children
Children ages 5 to 11 years can now receive one-third of the adult dose, with two injections given three weeks apart
EHR Data Support Reported Effectiveness of Ad26.COV2.S Vaccine
Retrospective study showed incidence rate ratio of 0.26 for SARS-CoV-2 infection in vaccinated persons versus unvaccinated controls
Cerebral Venous Sinus Thrombosis Rate Up After Ad26.COV2.S Shot
Postvaccination CVST rate 5.1-fold higher among women compared with pre-COVID-19 pandemic rate
FDA Delays Decision on Moderna COVID-19 Vaccine for Younger Teens
Agency said on Friday it needs more time to assess emerging international data on whether the vaccine increases the risk for myocarditis